Skip to main content

Qiming Venture Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

399
Companies
$20.5B
Total invested
$53.4M
Avg. check
36
Industries
Biotechnology 11Health Care 9Medical 8Pharmaceutical 7Therapeutics 5Information Technology 4+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 399
Swift Bridge Technologies
August 2025

Swift Bridge Technologies designs and produces quality and cost efficient cable assemblies.

Electronics · Tigard$1.0M Venture - Series Unknown
WAM Bio
August 2025

WAM Bio is a company operating in stealth mode.

Dover$1.5M Seed
Sharpa
July 2025

Sharpa is a robotics company that develops robots and core robotic components for real-world deployment of robotic applications.

Artificial Intelligence (AI) · Singapore$100.0M Series A
TigerGraph
July 2025

TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.

Analytics · Redwood CityVenture - Series Unknown
Renasant Bio
July 2025

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Biotechnology · Berkeley$54.5M Seed
Sesame Therapeutics
July 2025

Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.

Medical · Plymouth$19.0M Series A
Rhino Federated Computing
May 2025

Rhino Federated Computing provides a platform for AI collaboration enterprises to accelerate data strategies and to expand AI use cases.

Artificial Intelligence (AI) · Boston$15.0M Series A
Insilico Medicine
March 2025

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI) · Cambridge$123.0M Series E
Neuro3 Therapeutics
March 2025

Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

Medical · Hong Kong$3.5M Seed
Caidya
January 2025

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

Biotechnology · Raleigh$165.0M Private Equity
LetsGetChecked
January 2025

LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.

Biotechnology · Atlanta$165.0M Series F
Soda Health
December 2024

Soda Health is a healthcare technology company dedicated to eliminating health inequities through social determinants of health.

Health Care · Chicago$54.2M Series B
Tupos Therapeutics
November 2024

The company is currently operating in Stealth Mode.

Oakland$41.0M Seed
Outpace Bio
August 2024

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Biotechnology · Seattle$144.0M Series B
Emulate
March 2024

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Biotechnology · Boston$47.1M Series F
Clique
March 2024

The Clique Compute Coordination Network organizes various heterogeneous compute resources & allocates them efficiently to applications.

Artificial Intelligence (AI) · Stanford$8.0M Series A
GenEdit
January 2024

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Biotechnology · South San Francisco$24.0M Series A
DeBank
January 2024

DeBank creates a cryptocurrency wallet that allows users to access decentralized finance services.

Blockchain · Singapore$11.0M Series B
Sinogen Biopharma
December 2023

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Biopharma · BostonSeries B
Complete Omics
November 2023

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

Biotechnology · Baltimore$10.0M Series A
Manta Network
July 2023

Manta Network is building a secure and interoperable future with Zero-Knowledge.

Blockchain · Boston$25.0M Series A
AskGene Pharma
July 2023

AskGene Pharma is a pharmaceuticals company.

Biotechnology · CamarilloSeries A
P0x Labs
July 2023

P0x Labs is the team behind Manta Network is a privacy-preserving technology operating on the Polkadot blockchain.

Blockchain · Boston$25.0M Series A
Elevation Oncology
June 2023

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Biopharma · New York$50.0M Post-IPO Equity

Where Qiming Venture Partners invests

Biotechnology11
Health Care9
Medical8
Pharmaceutical7
Therapeutics5
Information Technology4

About Qiming Venture Partners's portfolio

How many companies has Qiming Venture Partners invested in?▸

Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qiming Venture Partners invest in?▸

Qiming Venture Partners's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 36 different industry categories.

What is Qiming Venture Partners's largest investment?▸

Among tracked funding rounds, Caidya received $165.0M in a Private Equity round. Qiming Venture Partners's total known invested capital is $20.5B.

What is the average investment size for Qiming Venture Partners?▸

Qiming Venture Partners's average investment size is $53.4M across its portfolio of 399 companies.

What are Qiming Venture Partners's most recent investments?▸

Recent Qiming Venture Partners portfolio additions include Swift Bridge Technologies, WAM Bio, Sharpa, TigerGraph, Renasant Bio. These companies were founded in 2020 or later.

Reach the founders behind these 399 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →